SCHEMBL3985351

SCHEMBL3985351

CN1CCn2c(c(O)c3c(=O)n(Cc4ccccc4)nc(N)c32)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.36
GAA P10253 1/20 0.36
KDM4E B2RXH2 1/20 0.36
PDE5A O76074 4/20 0.36
ALDH1A1 P00352 4/20 0.35
TSHR P16473 3/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
ADORA1 P30542 2/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
PDE6D O43924 1/20 0.35
PDE6A P16499 1/20 0.35
PDE6G P18545 1/20 0.35
ADORA2B P29275 1/20 0.35
PDE6B P35913 1/20 0.35
PDE6C P51160 1/20 0.35
PDE6H Q13956 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3985461 0.91 PDE5A (0.39) POLBGAAPDE5AMAPTADORA1
SCHEMBL3983836 0.90 PKM (0.39) KDM4EALDH1A1MAPTTP53
SCHEMBL3991213 0.85 TRAP1 (0.34)
SCHEMBL3985863 0.82 PKM (0.35) GAAALDH1A1TSHRLMNAMAPT
SCHEMBL3989304 0.81 LMNA (0.41) POLBALDH1A1LMNAMAPTTP53
SCHEMBL3986662 0.81 GAA (0.38) POLBGAAKDM4EPDE5AALDH1A1
SCHEMBL3992564 0.81 PDE5A (0.38) POLBKDM4EPDE5AALDH1A1TSHR
SCHEMBL3983532 0.80 PKM (0.44) GAAKDM4EALDH1A1TSHRMAPT
SCHEMBL3985459 0.80 SMN1; SMN2 (0.40) POLBKDM4EALDH1A1TSHRLMNA
SCHEMBL3983972 0.79 RXFP1 (0.40) POLBKDM4EALDH1A1MAPTADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP claimed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US claimed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US claimed
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP disclosed
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP disclosed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US disclosed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US disclosed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US disclosed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US disclosed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US disclosed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287394-A1 Hiv Integrase Inhibitors DHPS, DPYD, TYMP POLB 80/4885GAA 3093/4885KDM4E 377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.